Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00170703 · ClinicalTrials.gov registry record · Phase 1

Assessment of Cortical Stimulation Combined With Rehabilitation to Enhance Recovery in Broca's Aphasia.

A Phase 1 study of Stroke and Broca's Aphasia, sponsored by Northstar Neuroscience.

Completed
Registry status
Phase 1
Development phase
8
Enrollment target
2
Study locations

NCT00170703 is a Phase 1 study of Stroke and Broca's Aphasia that has completed, run by Northstar Neuroscience. The registered enrollment target is 8 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00170703, a Phase 1 study of Stroke and Broca's Aphasia, has completed, sponsored by Northstar Neuroscience.

COMPLETED
Registry status
Phase 1
Development phase
8 participants
Enrollment target
2
Study locations

Study Summary

The primary objective of this feasibility study is to evaluate the safety and effectiveness of targeted sub-threshold epidural cortical stimulation delivered concurrent with speech-language rehabilitation activities to enhance recovery in study subjects suffering from Broca's aphasia (the inability to speak or to organize the muscular movements for speech), following a stroke.

Conditions Studied

Interventions

  • DEVICE Cortical Electrical Stimulation

Study Locations (2)

Illinois

  • Rehabilitation Institute of Chicago - Chicago
  • Univ. of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2004-12
Est. Completion 2007-09
Phase Phase 1

Sponsor

Northstar Neuroscience

2 total trials

What the Registry Record Tells You About NCT00170703

The ClinicalTrials.gov registry entry for NCT00170703 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Northstar Neuroscience, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Cortical Electrical Stimulation is the first listed.

NCT00170703 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT00170703 about?

NCT00170703 is a clinical study titled "Assessment of Cortical Stimulation Combined With Rehabilitation to Enhance Recovery in Broca's Aphasia.". The primary objective of this feasibility study is to evaluate the safety and effectiveness of targeted sub-threshold epidural cortical stimulation delivered concurrent with speech-language rehabilitation activities to enhance recovery in study subjects suffering from Broca's aphasia (the inability ...

What is the current status of trial NCT00170703?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2004-12. Estimated completion is 2007-09.

What conditions does trial NCT00170703 study?

This clinical trial studies the following conditions: Stroke, Broca's Aphasia.

What interventions are being tested in trial NCT00170703?

The interventions under investigation include: Cortical Electrical Stimulation (DEVICE).

Who is sponsoring clinical trial NCT00170703?

This trial is sponsored by Northstar Neuroscience, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00170703 being conducted?

This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.